Let’s be perfectly clear: in no case would the pharmaceutical company be taking a loss. They just wouldn’t be making enough money.
Of course there is a cost to producing the therapy, maintaining equipment, training physicians; and the number of people who need this therapy is very small. So what? That just makes the therapy cost more per patient. Insurance premiums might go up a tiny bit, taxes might go up a tiny bit, depending on the healthcare system where you are.
Let’s be perfectly clear: in no case would the pharmaceutical company be taking a loss. They just wouldn’t be making enough money.
Of course there is a cost to producing the therapy, maintaining equipment, training physicians; and the number of people who need this therapy is very small. So what? That just makes the therapy cost more per patient. Insurance premiums might go up a tiny bit, taxes might go up a tiny bit, depending on the healthcare system where you are.
deleted by creator
If a therapy costs too much, insurance will no longer pay for it.
And when insurance decides not to pay for a therapy that is only used by a handful of people, there are often only a handful of complaints.